Edwards Lifesciences Corporation (EW) Stock

Healthcare · Medical Devices · Member of S&P 500

Edwards Lifesciences Corporation (EW) closed at USD 86.45 on 2026-10-14, a change of +5.2 % over the past year, with a market capitalization of USD 50.73B.

Edwards Lifesciences Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Edwards Lifesciences Corporation key figures

Previous close

USD 86.45 (2026-10-14)

1-year change

+5.2 %

Market cap

USD 50.73B

Enterprise value

USD 47.34B

P/E ratio (trailing)

52.44

P/E ratio (forward)

26.09

EPS (trailing)

1.68

EPS (forward)

3.38

PEG ratio

1.84

Price to book

4.78

Revenue growth

13.6 %

Earnings growth

-25.4 %

Dividend per share (trailing)

0.00

Short ratio

2.78

Employees

16,000

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Edwards Lifesciences Corporation and compare it with other stocks.